What's new in autism spectrum disorder? Harvard Review of Psychiatry presents research update

New findings on topics ranging from genetic causes to meeting the needs of college students 'on the spectrum'

2014-03-10

(Press-News.org) Philadelphia, Pa. (March 10, 2014) – Recent years have seen exciting progress in key areas of research on autism spectrum disorders (ASD): from possible genetic causes, to effective treatments for common symptoms and clinical problems, to promoting success for young people with ASD entering college. Updates on these and other advances in ASD research are presented in the March special issue of Harvard Review of Psychiatry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

"Autism is one of the most challenging disorders to treat and the public health concerns associated with the disorder are numerous due to its burden on the individual, on the family and on society," write guest editors Drs Jean A. Frazier of University of Massachusetts Medical School and Christopher J. McDougle of Harvard Medical School. The special issue provides a timely update on research into the causes, important clinical issues, and evidence-based treatments for ASD.

Updates on ASD Research in Six Key Areas Leading experts provide state-of-the-art reviews on six topics: the genetics of ASD; the use of psychoactive drugs; symptoms of special clinical problems, including obesity, gastrointestinal problems, and sensory issues; and transitioning to college.

Genetics. Over the last few years, there have been "unprecedented advances" in understanding the genetic causes of ASD. Hundreds of genes conferring varying degrees of ASD risk have been identified to date. Many of these genes also appear to be risk factors for related neurodevelopmental disorders and psychiatric problems. While many unanswered questions remain, it may soon be possible to make specific genetic diagnoses in children with ASD.

Psychoactive medications. Despite limited evidence, psychotropic drugs are widely used to manage behavior problems and mental health disorders in children with ASD. For medication classes—including antidepressants and stimulants—effectiveness may differ for youth versus adults with ASD. New treatments affecting specific neurotransmitters and the hormone oxytocin are under development, and may help in targeting the "core symptoms" of ASD.

Obesity. Obesity is a common problem with a major impact on the health of children with ASD. Some ASD-related genes may also promote obesity; the same is true for antipsychotic drugs used to help manage behavior problems. Other contributing factors may include sleep disorders and barriers to getting enough exercise. Childhood obesity and related health issues may be a "significant threat" to the health and quality of life of children with ASD.

Gastrointestinal issues. Children with ASD also have high rates of gastrointestinal symptoms and disorders. Some genes linked to ASD may also play a role in gastrointestinal disturbances, with a possible link to immune system dysfunction. There's also emerging evidence of a potential "gut-brain" connection, with gastrointestinal dysfunction contributing to the development or severity of ASD symptoms.

Sensory symptoms. Children with ASD have various abnormalities of sensory function, including both over- and under-responsivity as well as "sensory seeking behavior." Although the neurobiology of these sensory symptoms remains unclear, some researchers suggest they are related to known abnormalities of brain structure and function. Recent studies show that sensory symptoms are related to other ASD-related symptoms and behaviors; more research is needed to demonstrate the effectiveness of "sensory integration therapy" and other occupational therapy approaches.

Preparing for college. The final article highlights the need for new approaches to meeting the needs of "high-functioning" ASD patients entering college. Students "on the spectrum" transitioning to college are at risk of both academic and social problems, and may benefit from accommodation and supports. Based on a growing body of research, a set of recommendations for developing more effective transition plans for children with ASD are proposed.

Along with the editors of Harvard Review of Psychiatry, Drs Frazier and McDougal hope their special issue will provide a useful update for clinicians caring for the growing numbers of individuals and families living with ASD. They conclude, "Clearly, more research is needed on every level for the field to help support and treat individuals on the spectrum so that they can optimize their developmental trajectory and as adults become integral members of our work force."

INFORMATION: About the Harvard Review of Psychiatry The Harvard Review of Psychiatry is the authoritative source for scholarly reviews and perspectives on a diverse range of important topics in psychiatry. Founded by the Harvard Medical School Department of Psychiatry, the journal is peer-reviewed and not industry sponsored. It is the property of Harvard University and is affiliated with all of the Departments of Psychiatry at the Harvard teaching hospitals. Articles encompass all major issues in contemporary psychiatry, including (but not limited to) neuroscience, psychopharmacology, psychotherapy, history of psychiatry, and ethics.

About Wolters Kluwer Health Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health's customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2012 annual revenues of €3.6 billion ($4.6 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Follow our official Twitter handle: @WKHealth.

ELSE PRESS RELEASES FROM THIS DATE:

Phosphorylation of tau protein in rats subjected to cerebral ischemia-reperfusion injury

2014-03-10

Transient brain ischemia has been shown to induce hyperphosphorylation of the microtu-bule-associated protein tau. To further determine the mechanisms underlying these processes, Dr, Bo Song and co-workers from School of Life Sciences, Tsinghua University in China found for the first time that the interaction of tau with glycogen synthase kinase (GSK)-3β and protein phosphatase 2A is altered during transient brain ischemia. In addition, the researchers found that the neuroprotective function of lithium chloride may depend partly on the altered phosphorylation of tau, ...

Pretreatment with SSTF prevents hippocampal neuronal apoptosis due to cerebral infarction

2014-03-10

Focal cerebral ischemia-reperfusion may lead to neuronal loss in the hippocampus, which is regarded as one of the basic pathological mechanisms underlying cognitive impairment. The neuronal apoptosis plays an important role in cerebral infarction, determining the number of loss of neurons and infarct volume. Growing evidence has suggested that Chinese herbs can inhibit hippocampal apoptosis caused by ischemia-reperfusion. Prof. Shumin Zhao and team from Chengde Medical College in China pretreated rats with scutellaria baicalensis stem-leaf total flavonoid (SSTF) intragastrically ...

Agroforestry can ensure food security and mitigate the effects of climate change in Africa

2014-03-10

Agroforestry can help to achieve climate change mitigation and adaptation while at the same time providing livelihoods for poor smallholder farmers in Africa. Scientists at the World Agroforestry Centre (ICRAF) say agroforestry - which is an integrated land use management technique that incorporates trees and shrubs with crops and livestock on farms - could be a win-win solution to the seemingly difficult choice between reforestation and agricultural land use, because it increases the storage of carbon and may also enhance agricultural productivity. In a special issue ...

Smokers' brains biased against negative images of smoking

2014-03-10

This news release is available in French. What if the use of a product influenced your perception of it, making you even more susceptible to its positive aspects and altering your understanding of its drawbacks? This is precisely what happens with cigarettes in chronic smokers, according to a recent study by the Institut universitaire en santé mentale de Montréal and Université de Montréal. The study showed that chronic smokers have altered emotional reactions when they are exposed to negative and positive images associated with tobacco. "We observed a bias depending ...

All paths lead to Rome, even the path to condensed matter theory

2014-03-10

Italian physicist Carlo Di Castro, professor emeritus at the University of Rome Sapienza, Italy, shares his recollections of how theoretical condensed matter physics developed in Rome, starting in the 1960s. Luisa Bonolis, a researcher at the Max Planck Institute for the History of Science in Berlin, Germany, invited Di Castro to reflect upon his research career, which he did in an interview published in EPJ H. In this unique document, Di Castro talks about his upbringing during the second World War. He also explains how this childhood experience later influenced his ...

Two-dimensional material shows promise for optoelectronics

2014-03-10

A team of MIT researchers has used a novel material that's just a few atoms thick to create devices that can harness or emit light. This proof-of-concept could lead to ultrathin, lightweight, and flexible photovoltaic cells, light emitting diodes (LEDs), and other optoelectronic devices, they say. Their report is one of three papers by different groups describing similar results with this material, published in the March 9 issue of Nature Nanotechnology. The MIT research was carried out by Pablo Jarillo-Herrero, the Mitsui Career Development Associate Professor of Physics, ...

Doctors often uncertain in ordering, interpreting lab tests

2014-03-10

A survey of primary care physicians suggests they often face uncertainty in ordering and interpreting clinical laboratory tests, and would welcome better electronic clinical decision support tools. The results of the survey, sponsored by the U.S. Centers for Disease Control and Prevention, were published in the March-April issue of The Journal of the American Board of Family Medicine. "The optimal testing pathways to arrive at correct diagnoses is changing, so it is difficult for primary care physicians to keep up with new and efficient testing algorithms," says Dr. John ...

Study finds pill may represent promising treatment for stubborn blood cancers

2014-03-10

(WASHINGTON, March 10, 2014) – A pill that suppresses a key regulator of cancer growth may provide hope to relapsed leukemia and lymphoma patients running out of treatment options for their aggressive, treatment-resistant disease, according to three reports* published online today in Blood, the journal of the American Society of Hematology. Patients with blood cancer are typically administered a combination of chemotherapy and immunotherapy, the latter using the body's own immune system to help fight disease, as a first line of treatment. While chemotherapy has traditionally ...

Moffitt Cancer Center pioneers worldwide standard in diagnosing melanoma

2014-03-10

Moffitt Cancer Center researchers have been instrumental in making significant improvements to the diagnostic procedure called sentinel node biopsy for melanoma patients and teaching this procedure to physicians from around the world. Sentinel nodes are the first lymph nodes to which cancer cells from a primary tumor like melanoma will spread. In the sentinel node biopsy procedure, a radioactive tracer and a blue-colored dye are injected at or near the melanoma site on the skin and tracked to the first lymph node(s). These sentinel nodes are then surgically removed and ...

Genomic test to rule out obstructive CAD may reduce need for more invasive diagnostics

2014-03-10

New Rochelle, NY, March 10, 2014–Nearly $7 billion is spent each year in the U.S. on diagnostic testing of the estimated three million people with symptoms of obstructive coronary artery disease (CAD). A new blood test that detects specific genes activated in individuals with obstructive CAD could exclude the diagnosis without the need for imaging studies or more invasive tests, reducing health care costs, as described in an article in Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Population ...